Emergent Biosolutions (EBS) Issues Q3 Miss
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.55 -3.68%
EPS Growth %: -138.7%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
MLKN, KBH, WOR, More
EPS Growth %: -138.7%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
MLKN, KBH, WOR, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.04, $0.06 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $58.8 million versus the consensus estimate of $63.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
- LuxExperience B.V. (LUXE) Misses Q2 EPS by 11c
- Children's Place (PLCE) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
